A recent study showed that patients with newly diagnosed systemic autoimmune rheumatic diseases are at a significantly increased risk for interstitial lung disease (ILD). In that study, the incidence rate for ILD was greatest among patients with systemic sclerosis. Based on what you have seen in your practice, patients with which systemic autoimmune rheumatic disease are most likely to develop ILD?
